NEW YORK (GenomeWeb News) – Identitas and Akesogen today announced a commercial partnership they said will allow forensics investigators "to generate more comprehensive leads from DNA samples than had previously been possible."

The companies have entered into a licensing deal providing Akesogen access to Identitas' ISAS software, which interrogates SNPs for a profile that describes the physical appearance of an individual. Akesogen will offer an end-to-end genetic analysis package powered by ISAS.

Financial and other terms of the agreement were not disclosed.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Researchers hope to tease out the signature effects that different carcinogens leave on the genome to determine their contributions to disease, Mosaic reports.

The Wall Street Journal looks into the cost of new gene therapies.

An Imperial College London-led team reports that it was able to use a gene drive to control a population of lab mosquitos.

In PNAS this week: genomic effects of silver fox domestication, limited effect of mitochondrial mutations on aging in fruit flies, and more.